Injective INJ
Current Price
$5.76 +8.18%
$0.6000 Daily Range (10.42%)
$5.31$5.91
$90.52M Daily Volume
1,028 BTC
Vol/MktCap: 15.70%
Market Performance
0.12% Relative BTC Volume
The total volume of Injective is $90.52M over the past 24 hours, compared to $77.52B total Bitcoin volume.
Hourly Moving Average
8 SMA $5.76 -0.03%
13 SMA $5.65 +1.87%
21 SMA $5.58 +3.18%
55 SMA $5.49 +4.99%
144 SMA $5.83 -1.24%
Price Performance
-0.39% 1 Hour Change
$5.76 from $5.78
-7.88% 7 Day Change
-$0.4541 from $6.21
-31.75% 14 Day Change
-$1.83 from $7.59
-31.76% 30 Day Change
-$1.83 from $7.59
All Time High
March 14, 2024
$52.62 -89.07%
-$46.87 vs. now
24H Change
41.25M USD +7.71%
469 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.01 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
16.14M INJ
traded over past 24 hours
16.14% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $5.89, reflecting an impressive 24-hour change of 8.67%. The daily range has been tight at just 0.58%, with a high of $5.89 and a low of $5.31, indicating a bullish sentiment in the short term despite a recent downtrend over the past week, month, and two weeks.
The trading volume stands at approximately $86.55 million, representing 14.69% of the market cap, suggesting healthy liquidity. Technical indicators show that short-term moving averages (8 SMA at $5.55, 13 SMA at $5.52) are trending positively, while the 144 SMA at $5.86 indicates a slight resistance level.
The 1-hour RSI is at 73, indicating overbought conditions, while the 7-day RSI at 46 suggests that the asset is nearing equilibrium after a longer-term decline of 7.45% over the past week and more significant drops of 28% and 30% over the last two and four weeks, respectively. This divergence points to potential short-term profit-taking, particularly given the recent volatility.
Fundamentally, the current price is significantly below its all-time high of $52.62, reached earlier in March 2024, suggesting substantial room for recovery but also highlighting the risks associated with its current volatility. The short-term bullish movement could be supported by increased market interest, but the longer-term bearish trend requires cautious navigation.
Given the current price action, strong short-term momentum, but longer-term bearish indicators, the recommendation for Injective (INJ) is to Hold. While the recent gains could indicate a reversal, the broader downtrend and overbought signals warrant a wait-and-see approach to assess further price stability.
The trading volume stands at approximately $86.55 million, representing 14.69% of the market cap, suggesting healthy liquidity. Technical indicators show that short-term moving averages (8 SMA at $5.55, 13 SMA at $5.52) are trending positively, while the 144 SMA at $5.86 indicates a slight resistance level.
The 1-hour RSI is at 73, indicating overbought conditions, while the 7-day RSI at 46 suggests that the asset is nearing equilibrium after a longer-term decline of 7.45% over the past week and more significant drops of 28% and 30% over the last two and four weeks, respectively. This divergence points to potential short-term profit-taking, particularly given the recent volatility.
Fundamentally, the current price is significantly below its all-time high of $52.62, reached earlier in March 2024, suggesting substantial room for recovery but also highlighting the risks associated with its current volatility. The short-term bullish movement could be supported by increased market interest, but the longer-term bearish trend requires cautious navigation.
Given the current price action, strong short-term momentum, but longer-term bearish indicators, the recommendation for Injective (INJ) is to Hold. While the recent gains could indicate a reversal, the broader downtrend and overbought signals warrant a wait-and-see approach to assess further price stability.
Updated 209 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Nvidia shares rise 2.5% amid optimism over US-China trade relations
Nvidia shares rise on US-China trade hopes as investors anticipate improved access to Chinas AI chip market amid easing tensions.

Monad Token Defies Market Rout With Sharp Post-Launch Rally
Monad’s MON token surged more than 35% on launch day, breaking the industry’s usual post-airdrop decline.

Elon Musk’s New X Feature Skyrockets Racism and Crypto Kidnapping Concerns
The new location-visibility feature on X has sparked an immediate wave of racism, harassment, and doxxing across Crypto Twitter. The update has also raised serious safety…

XRP jumps 8% as Franklin Templeton, Grayscale ETFs begin trading
The investment vehicle tied to XRP launched amid other offerings from Grayscale, Bitwise Asset Management and Canary Capital.